LIWANLI Innovation Co Ltd (3054) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.056x

Based on the latest financial reports, LIWANLI Innovation Co Ltd (3054) has a cash flow conversion efficiency ratio of -0.056x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$-41.53 Million ≈ $-1.31 Million USD) by net assets (NT$743.29 Million ≈ $23.42 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See LIWANLI Innovation Co Ltd defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

LIWANLI Innovation Co Ltd - Cash Flow Conversion Efficiency Trend (2005–2024)

This chart illustrates how LIWANLI Innovation Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

LIWANLI Innovation Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of LIWANLI Innovation Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Cambridge Acquisition Corp. Class A Ordinary Shares NASDAQ:CAQ	-0.001x
Robot Consulting Co., Ltd. ADS NASDAQ:LAWR	N/A
Inogen Inc NASDAQ:INGN	-0.037x
AVITA Medical Inc F:51KB	2.255x
New World Resources Ltd AU:NWC	-0.015x
Cartesian Therapeutics Inc. NASDAQ:RNAC	0.149x
Garuda Construction & Engineering NSE:GARUDA	0.011x
Alector Inc NASDAQ:ALEC	-1.360x

Annual Cash Flow Conversion Efficiency for LIWANLI Innovation Co Ltd (2005–2024)

The table below shows the annual cash flow conversion efficiency of LIWANLI Innovation Co Ltd from 2005 to 2024. For the full company profile with market capitalisation and key ratios, see 3054 stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	NT$752.96 Million ≈ $23.72 Million	NT$14.20 Million ≈ $447.44K	0.019x	+129.36%
2023-12-31	NT$783.51 Million ≈ $24.68 Million	NT$-50.34 Million ≈ $-1.59 Million	-0.064x	-162.66%
2022-12-31	NT$765.36 Million ≈ $24.11 Million	NT$78.48 Million ≈ $2.47 Million	0.103x	+250.54%
2021-12-31	NT$897.52 Million ≈ $28.28 Million	NT$-61.13 Million ≈ $-1.93 Million	-0.068x	-74.07%
2020-12-31	NT$936.03 Million ≈ $29.49 Million	NT$-36.63 Million ≈ $-1.15 Million	-0.039x	+65.38%
2019-12-31	NT$965.79 Million ≈ $30.43 Million	NT$-109.16 Million ≈ $-3.44 Million	-0.113x	+5.90%
2018-12-31	NT$1.02 Billion ≈ $32.29 Million	NT$-123.09 Million ≈ $-3.88 Million	-0.120x	-291.91%
2017-12-31	NT$1.53 Billion ≈ $48.34 Million	NT$96.03 Million ≈ $3.03 Million	0.063x	-15.97%
2016-12-31	NT$1.51 Billion ≈ $47.66 Million	NT$112.68 Million ≈ $3.55 Million	0.074x	+138.61%
2015-12-31	NT$1.09 Billion ≈ $34.36 Million	NT$34.04 Million ≈ $1.07 Million	0.031x	-91.83%
2014-12-31	NT$1.24 Billion ≈ $39.01 Million	NT$473.04 Million ≈ $14.90 Million	0.382x	+686.36%
2013-12-31	NT$1.38 Billion ≈ $43.43 Million	NT$-89.82 Million ≈ $-2.83 Million	-0.065x	+52.82%
2012-12-31	NT$753.19 Million ≈ $23.73 Million	NT$-104.02 Million ≈ $-3.28 Million	-0.138x	+30.01%
2011-12-31	NT$799.59 Million ≈ $25.19 Million	NT$-157.77 Million ≈ $-4.97 Million	-0.197x	-325.30%
2010-12-31	NT$895.33 Million ≈ $28.21 Million	NT$78.41 Million ≈ $2.47 Million	0.088x	+9.91%
2009-12-31	NT$1.12 Billion ≈ $35.36 Million	NT$89.43 Million ≈ $2.82 Million	0.080x	+4.20%
2008-12-31	NT$666.68 Million ≈ $21.00 Million	NT$50.98 Million ≈ $1.61 Million	0.076x	-3.33%
2005-12-31	NT$462.99 Million ≈ $14.59 Million	NT$36.62 Million ≈ $1.15 Million	0.079x	--

About LIWANLI Innovation Co Ltd

TW:3054 Taiwan Drug Manufacturers - Specialty & Generic

Market Cap

$172.28 Million

NT$5.47 Billion TWD

Market Cap Rank

#17239 Global

#882 in Taiwan

Share Price

NT$67.80

Change (1 day)

+0.15%

52-Week Range

NT$22.10 - NT$90.30

All Time High

NT$90.30